Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1994
Does clinical experience with a treatment regimen affect survival of lung cancer patients? An analysis based on consecutive randomized trials of the Medical Research Council in small cell and non-small cell tumours. Medical Research Council Lung Cancer Working PartyJ G Wheeler, D Machin, M J Campbell, et al.
Tubercle|September 1, 1981
Serum uric acid concentrations and arthralgia among patients treated with pyrazinamide-containing regimens in Hong Kong and SingaporeP J Jenner, G A Ellard, W G Allan, et al.
QJM : Monthly Journal of the Association of Physicians|July 17, 2004
Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-upJ I G Strang, A J Nunn, D A Johnson, et al.
Tubercle|June 1, 1983
Amikacin in the treatment of pulmonary tuberculosisB W Allen, D A Mitchison, Y C Chan, et al.
The American Review of Respiratory Disease|December 1, 1988
HLA typing in the Hong Kong Chest Service/British Medical Research Council study of factors associated with the breakdown to active tuberculosis of inactive pulmonary lesionsB R Hawkins, D A Higgins, S L Chan, et al.
Thorax|October 1, 1975
Survey of the sputum cytology service in England and WalesN C Oswald, K F Hinson, G Canti, et al.
Thorax|February 5, 2004
BTS randomised feasibility study of active symptom control with or without chemotherapy in malignant pleural mesothelioma: ISRCTN 54469112M F Muers, R M Rudd, M E R O'Brien, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC). Medical Research Council Lung Cancer Working PartyN Thatcher, P I Clark, D B Smith, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 1992
The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosisS L Chan, W W Yew, W K Ma, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC)A Gregor, A Cull, R J Stephens, et al.
Pageof 5